Distinct immune profiles and clinical outcomes in sepsis subphenotypes based on temperature trajectories

IF 27.1 1区 医学 Q1 CRITICAL CARE MEDICINE
Sivasubramanium V. Bhavani, Alexandra Spicer, Pratik Sinha, Albahi Malik, Carlos Lopez-Espina, Lee Schmalz, Gregory L. Watson, Akhil Bhargava, Shah Khan, Dennys Urdiales, Lincoln Updike, Alon Dagan, Hugo Davila, Carmen Demarco, Neil Evans, Falgun Gosai, Karthik Iyer, Niko Kurtzman, Ashok V. Palagiri, Matthew Sims, Scott Smith, Anwaruddin Syed, Deesha Sarma, Bobby Reddy, Philip A. Verhoef, Matthew M. Churpek
{"title":"Distinct immune profiles and clinical outcomes in sepsis subphenotypes based on temperature trajectories","authors":"Sivasubramanium V. Bhavani, Alexandra Spicer, Pratik Sinha, Albahi Malik, Carlos Lopez-Espina, Lee Schmalz, Gregory L. Watson, Akhil Bhargava, Shah Khan, Dennys Urdiales, Lincoln Updike, Alon Dagan, Hugo Davila, Carmen Demarco, Neil Evans, Falgun Gosai, Karthik Iyer, Niko Kurtzman, Ashok V. Palagiri, Matthew Sims, Scott Smith, Anwaruddin Syed, Deesha Sarma, Bobby Reddy, Philip A. Verhoef, Matthew M. Churpek","doi":"10.1007/s00134-024-07669-0","DOIUrl":null,"url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Purpose</h3><p>Sepsis is a heterogeneous syndrome. Identification of sepsis subphenotypes with distinct immune profiles could lead to targeted therapies. This study investigates the immune profiles of patients with sepsis following distinct body temperature patterns (i.e., temperature trajectory subphenotypes).</p><h3 data-test=\"abstract-sub-heading\">Methods</h3><p>Hospitalized patients from four hospitals between 2018 and 2022 with suspicion of infection were included. A previously validated temperature trajectory algorithm was used to classify study patients into temperature trajectory subphenotypes. Microbiological profiles, clinical outcomes, and levels of 31 biomarkers were compared between these subphenotypes.</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>The 3576 study patients were classified into four temperature trajectory subphenotypes: hyperthermic slow resolvers (<i>N</i> = 563, 16%), hyperthermic fast resolvers (<i>N</i> = 805, 23%), normothermic (<i>N</i> = 1693, 47%), hypothermic (<i>N</i> = 515, 14%). The mortality rate was significantly different between subphenotypes, with the highest rate in hypothermics (14.2%), followed by hyperthermic slow resolvers 6%, normothermic 5.5%, and lowest in hyperthermic fast resolvers 3.6% (<i>p</i> &lt; 0.001). After multiple testing correction for the 31 biomarkers tested, 20 biomarkers remained significantly different between temperature trajectories: angiopoietin-1 (Ang-1), C-reactive protein (CRP), feline McDonough sarcoma-like tyrosine kinase 3 ligand (Flt-3l), granulocyte colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin (IL)-15, IL-1 receptor antagonist (RA), IL-2, IL-6, IL-7, interferon gamma-induced protein 10 (IP-10), monocyte chemoattractant protein-1 (MCP-1), human macrophage inflammatory protein 3 alpha (MIP-3a), neutrophil gelatinase-associated lipocalin (NGAL), pentraxin-3, thrombomodulin, tissue factor, soluble triggering receptor expressed on myeloid cells-1 (sTREM-1), and vascular cellular adhesion molecule-1 (vCAM-1).The hyperthermic fast and slow resolvers had the highest levels of most pro- and anti-inflammatory cytokines. Hypothermics had suppressed levels of most cytokines but the highest levels of several coagulation markers (Ang-1, thrombomodulin, tissue factor).</p><h3 data-test=\"abstract-sub-heading\">Conclusion</h3><p>Sepsis subphenotypes identified using the universally available measurement of body temperature had distinct immune profiles. Hypothermic patients, who had the highest mortality rate, also had the lowest levels of most pro- and anti-inflammatory cytokines.</p>","PeriodicalId":13665,"journal":{"name":"Intensive Care Medicine","volume":"39 1","pages":""},"PeriodicalIF":27.1000,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Intensive Care Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00134-024-07669-0","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CRITICAL CARE MEDICINE","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose

Sepsis is a heterogeneous syndrome. Identification of sepsis subphenotypes with distinct immune profiles could lead to targeted therapies. This study investigates the immune profiles of patients with sepsis following distinct body temperature patterns (i.e., temperature trajectory subphenotypes).

Methods

Hospitalized patients from four hospitals between 2018 and 2022 with suspicion of infection were included. A previously validated temperature trajectory algorithm was used to classify study patients into temperature trajectory subphenotypes. Microbiological profiles, clinical outcomes, and levels of 31 biomarkers were compared between these subphenotypes.

Results

The 3576 study patients were classified into four temperature trajectory subphenotypes: hyperthermic slow resolvers (N = 563, 16%), hyperthermic fast resolvers (N = 805, 23%), normothermic (N = 1693, 47%), hypothermic (N = 515, 14%). The mortality rate was significantly different between subphenotypes, with the highest rate in hypothermics (14.2%), followed by hyperthermic slow resolvers 6%, normothermic 5.5%, and lowest in hyperthermic fast resolvers 3.6% (p < 0.001). After multiple testing correction for the 31 biomarkers tested, 20 biomarkers remained significantly different between temperature trajectories: angiopoietin-1 (Ang-1), C-reactive protein (CRP), feline McDonough sarcoma-like tyrosine kinase 3 ligand (Flt-3l), granulocyte colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin (IL)-15, IL-1 receptor antagonist (RA), IL-2, IL-6, IL-7, interferon gamma-induced protein 10 (IP-10), monocyte chemoattractant protein-1 (MCP-1), human macrophage inflammatory protein 3 alpha (MIP-3a), neutrophil gelatinase-associated lipocalin (NGAL), pentraxin-3, thrombomodulin, tissue factor, soluble triggering receptor expressed on myeloid cells-1 (sTREM-1), and vascular cellular adhesion molecule-1 (vCAM-1).The hyperthermic fast and slow resolvers had the highest levels of most pro- and anti-inflammatory cytokines. Hypothermics had suppressed levels of most cytokines but the highest levels of several coagulation markers (Ang-1, thrombomodulin, tissue factor).

Conclusion

Sepsis subphenotypes identified using the universally available measurement of body temperature had distinct immune profiles. Hypothermic patients, who had the highest mortality rate, also had the lowest levels of most pro- and anti-inflammatory cytokines.

Abstract Image

基于体温轨迹的败血症亚型的不同免疫特征和临床结局
目的 败血症是一种异质性综合征。鉴别出具有不同免疫特征的败血症亚型可能有助于开发靶向疗法。本研究调查了脓毒症患者在不同体温模式(即体温轨迹亚型)下的免疫特征。方法纳入了2018年至2022年期间来自四家医院的疑似感染住院患者。采用先前验证过的体温轨迹算法将研究对象分为体温轨迹亚型。结果3576名研究患者被分为四种体温轨迹亚型:高热慢解者(N = 563,16%)、高热快解者(N = 805,23%)、常温者(N = 1693,47%)、低体温者(N = 515,14%)。不同亚型的死亡率有明显差异,低体温者的死亡率最高(14.2%),其次是高热慢解者 6%,常温者 5.5%,最低的是高热快解者 3.6%(p <0.001)。对测试的 31 种生物标记物进行多重检验校正后,20 种生物标记物在不同体温轨迹之间仍存在显著差异:血管生成素-1(Ang-1)、C 反应蛋白(CRP)、猫麦多肉瘤样酪氨酸激酶 3 配体(Flt-3l)、粒细胞集落刺激因子(G-CSF)、粒细胞-巨噬细胞集落刺激因子(GM-CSF)、白细胞介素(IL)-15、IL-1 受体拮抗剂(RA)、IL-2、IL-6、IL-7、γ-干扰素诱导蛋白 10(IP-10)、单核细胞趋化蛋白-1(MCP-1)、人巨噬细胞炎症蛋白 3 alpha(MIP-3a)、中性粒细胞明胶酶相关脂质钙蛋白(NGAL)、五肽-3、血栓调节蛋白、组织因子、髓样细胞上表达的可溶性触发受体-1(sTREM-1)和血管细胞粘附分子-1(vCAM-1)。高热快速和慢速分解者的大多数促炎和抗炎细胞因子水平最高。低体温者的大多数细胞因子水平受到抑制,但几种凝血标志物(Ang-1、血栓调节蛋白、组织因子)的水平最高。体温过低的患者死亡率最高,同时大多数促炎和抗炎细胞因子的水平也最低。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Intensive Care Medicine
Intensive Care Medicine 医学-危重病医学
CiteScore
51.50
自引率
2.80%
发文量
326
审稿时长
1 months
期刊介绍: Intensive Care Medicine is the premier publication platform fostering the communication and exchange of cutting-edge research and ideas within the field of intensive care medicine on a comprehensive scale. Catering to professionals involved in intensive medical care, including intensivists, medical specialists, nurses, and other healthcare professionals, ICM stands as the official journal of The European Society of Intensive Care Medicine. ICM is dedicated to advancing the understanding and practice of intensive care medicine among professionals in Europe and beyond. The journal provides a robust platform for disseminating current research findings and innovative ideas in intensive care medicine. Content published in Intensive Care Medicine encompasses a wide range, including review articles, original research papers, letters, reviews, debates, and more.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信